No Data
No Data
No Data
Pharmarise Holdings: Announcement regarding the dividends of surplus funds.
Pharmarise Holdings Faces Profit Decline, Eyes Recovery
Buy demand next week for Maesawa Chemical Industry and others.
[Buy demand for next week (table)] Code; Stock; Stock price impact; Buy demand; Credit multiplier; Closing price; Previous day comparison <9046>: Kobe Electric Railway; 390%; 35,900; 0.06; 2772; -3 <2796>: Farmalize; 345%; 7,600; 7.09; 635; -2 <3198>: SFP; 315%; 77,900; 0.15; 2163; -5 <8118>: King; 254%; 6,100; 62.03; 755; 0 <9428>: Crops; 20
Pharmarise Holdings To Go Ex-Dividend On May 29th, 2025 With 14 JPY Dividend Per Share
July 2nd (Japan Standard Time) - $Pharmarise Holdings(2796.JP)$ is trading ex-dividend on May 29th, 2025.Shareholders of record on May 31st, 2025 will receive 14 JPY dividend per share. The ex-dividen
Takashimaya revises upwards on February 25, operating profit of 55 billion yen (previously 50 billion yen).
Takashimaya <8233> announced a revision of its financial estimates for the fiscal year ending in February 2025. The operating revenue was revised upward from ¥497 billion to ¥511.4 billion, while the operating profit was revised upward from ¥50 billion to ¥55 billion, reflecting the strong performance of inbound sales in domestic department stores. The first quarter financial results for the February 2025 period showed an operating revenue of ¥120.125 billion, up 13.8% YoY, and an operating profit of ¥17.295 billion, up 56.7% YoY. [Positive rating] Intellix<8940> Revision | <
Pharmarise Holdings: Announcement of differences between financial estimates and actual results for the entire fiscal year of May Heisei 6
No Data